Cancer Family
Secondary Malignant Neoplasm
CI-CAN-00000346SMNExplore in graph →
4,275 active trials56 approved drugs532 evidence items
- NCIt
- C4968
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000346SMNExplore in graph →
Clinical trials
14,671 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,961)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00216216 | Pemetrexed in Patients With Chemosensitive and Chemoresistant Relapsed Small Cell Lung Cancer | terminated | Phase 2 | 43 | Hoosier Cancer Research NetworkOTHER | 1 | May 2, 2011 | clinicaltrials |
| NCT00317200 | A Study of Paclitaxel Plus Bevacizumab in Patients With Chemosensitive Relapsed Small Cell Lung Cancer | completed | Phase 2 | 34 | Hoosier Cancer Research NetworkOTHER | 1 | May 2, 2011 | clinicaltrials |
| NCT00403403 | A Study of Bevacizumab in Previously Untreated Extensive-Stage Small Cell Lung Cancer (SALUTE) | completed | Phase 2 | 102 | Genentech, Inc.INDUSTRY | 0 | Apr 29, 2011 | clinicaltrials |
| NCT01341132 | Evaluation of Cirrhosis and Malignant Hepatic Lesions Using Novel MR Contrast Agents | unknown | — | 75 | San Francisco Veterans Affairs Medical CenterFED | 1 | Apr 25, 2011 | clinicaltrials |
| NCT00921531 | Adjuvant Therapy With Thalidomide for Chemoembolization in Advanced Hepatocellular Carcinoma | unknown | Phase 3 | 200 | Fudan UniversityOTHER | 1 | Apr 19, 2011 | clinicaltrials |
| NCT01336049 | Nimotuzumab Plus Paclitaxel and Cisplatin as 1st Line Treatment for Esophageal Squamous Cell Cancer | unknown | Phase 2 | 70 | Peking UniversityOTHER | 1 | Apr 15, 2011 | clinicaltrials |
| NCT01259193 | Clinical Study of Sorafenib and Zoledronic Acid to Treat Advanced HCC | unknown | Phase 2 | 50 | Fudan UniversityOTHER | 1 | Apr 14, 2011 | clinicaltrials |
| NCT00005049 | Combination Chemotherapy in Treating Patients With Stage III Ovarian Epithelial Cancer or Gastrointestinal Cancer | completed | Phase 2 | 45 | NYU Langone HealthOTHER | 1 | Apr 6, 2011 | clinicaltrials |
| NCT01328223 | Study of Combined Sorafenib With Radiotherapy in Patients With Advanced Hepatocellular Carcinoma | unknown | — | 45 | China Medical University HospitalOTHER | 1 | Apr 4, 2011 | clinicaltrials |
| NCT01322477 | Contribution of F-18 Fluoro-Deoxy-Glucose PET/CT (Positron Emission Tomography) to the Assessment of HCC (Hepato-cellular Carcinoma) Treatment Efficiency(HCC) | unknown | — | 25 | Hadassah Medical OrganizationOTHER | 1 | Mar 24, 2011 | clinicaltrials |
| NCT01319942 | Combined Radiotherapy and Sorafenib in Patients With Hepatoma | unknown | — | 45 | China Medical University HospitalOTHER | 1 | Mar 22, 2011 | clinicaltrials |
| NCT00875381 | Analysis of Melanocytes (Pigment Cells) in Sun-Exposed Skin | completed | — | 100 | Mayo ClinicOTHER | 0 | Mar 15, 2011 | clinicaltrials |
| NCT00862303 | DC Vaccine Therapy Combined With Cytokine-Induced Killer Cell in Treating Patients With Renal Cell Carcinoma | unknown | Phase 1 / Phase 2 | 100 | Fuzhou General HospitalOTHER | 1 | Mar 8, 2011 | clinicaltrials |
| NCT01310062 | The Development of Diagnostic Biomarker Panels for Hepatitis and Liver Cancer | unknown | — | 1,600 | Ministry of Health, MalaysiaOTHER_GOV | 1 | Mar 7, 2011 | clinicaltrials |
| NCT00178698 | Hyperthermia/Thermal Therapy With Chemotherapy to Treat Inoperable or Metastatic Tumors(FR-WB-TT/che) | unknown | Phase 2 | 36 | The University of Texas Health Science Center, HoustonOTHER | 1 | Mar 3, 2011 | clinicaltrials |
| NCT00225927 | Trial Comparing Radioactive Seed Localization to Standard Procedure for Non-palpable Breast Cancers | completed | N/A | 333 | McMaster UniversityOTHER | 1 | Mar 2, 2011 | clinicaltrials |
| NCT00117351 | VELCADE in Previously Treated Patients With Stage IIIB and IV Bronchioloalveolar Carcinoma (BAC) and Adenocarcinoma With BAC Features | terminated | Phase 2 | — | Millennium Pharmaceuticals, Inc.INDUSTRY | 1 | Feb 17, 2011 | clinicaltrials |
| NCT00206219 | Head and Neck Phase III Iressa Versus Methotrexate Refractory: Iressa Versus Methotrexate (IMEX) | completed | Phase 3 | 477 | AstraZenecaINDUSTRY | 25 | Jan 27, 2011 | clinicaltrials |
| NCT00233636 | Iressa and Radiotherapy in the Treatment of the Locally Advanced Inoperable Squamous Cell Carcinoma of the Head and Neck | withdrawn | Phase 2 | 28 | AstraZenecaINDUSTRY | 1 | Jan 27, 2011 | clinicaltrials |
| NCT00065572 | Exploratory Study to Assess the Biological Activity of ZD6126 in Subjects With Newly Diagnosed Metastatic Renal Cell Carcinoma (Stage IV) | suspended | Phase 2 | — | AstraZenecaINDUSTRY | 1 | Jan 26, 2011 | clinicaltrials |
| NCT01281683 | Dynamic Contrast-enhanced Magnetic Resonance Imaging in Evaluation of Liver Functional Status and Treatment Efficacy in Patients With Hepatocellular Carcinoma After Locoregional Therapy | unknown | — | 60 | National Taiwan University HospitalOTHER | 1 | Jan 24, 2011 | clinicaltrials |
| NCT00502164 | Study to Assess Safety and Tolerability of AZD2171 After Multiple Doses in Patients With Advanced Prostate Cancer(AZD2171IL/0003) | completed | Phase 1 | 40 | AstraZenecaINDUSTRY | 1 | Jan 21, 2011 | clinicaltrials |
| NCT00411151 | Efficacy and Safety of Sunitinib in Metastatic Gastric Cancer | completed | Phase 2 | 52 | Johannes Gutenberg University MainzOTHER | 1 | Jan 20, 2011 | clinicaltrials |
| NCT01277653 | Study of PIVKA-II and AFP Measurement in Surveillance Program for Early Detection of Hepatocellular Carcinoma | unknown | — | 1,000 | Yonsei UniversityOTHER | 1 | Jan 17, 2011 | clinicaltrials |
| NCT00990860 | Study in Asia of the Combination of TACE With Sorafenib in HCC Patients(START) | unknown | Phase 2 | 36 | Taipei Veterans General Hospital, TaiwanOTHER_GOV | 1 | Jan 5, 2011 | clinicaltrials |
| NCT01270178 | Entecavir for Chronic Hepatitis B in Hepatocellular Carcinoma Patients Underwent Radiofrequency Ablation Therapy | unknown | — | 420 | Taipei Veterans General Hospital, TaiwanOTHER_GOV | 1 | Jan 5, 2011 | clinicaltrials |
| NCT00822991 | Sonazoid Enhanced Liver Cancer Trial for Early Detection | unknown | N/A | 760 | Kindai UniversityOTHER | 1 | Dec 30, 2010 | clinicaltrials |
| NCT01266707 | Antiangiogenic Peptide Vaccine Therapy in Treating Patient With Hepatocellular Carcinoma | unknown | Phase 1 | 9 | Fukushima Medical UniversityOTHER | 1 | Dec 24, 2010 | clinicaltrials |
| NCT01265472 | Comparison of Translocator Protein Expression and Binding Activity in Normal Tissue Versus Non Melanotic Malignancy | unknown | — | 100 | Rambam Health Care CampusOTHER | 0 | Dec 23, 2010 | clinicaltrials |
| NCT01254838 | Novel Peptide Vaccination for Patients With Advanced Renal Cell Carcinoma | completed | Phase 1 | — | Iwate Medical UniversityOTHER | 0 | Dec 7, 2010 | clinicaltrials |
| NCT00829192 | Phase II AK Study in Organ Transplant Patients | unknown | Phase 2 | 200 | Clinuvel Pharmaceuticals LimitedINDUSTRY | 7 | Dec 6, 2010 | clinicaltrials |
| NCT01249053 | Expression of Optic Atrophy Type 1 (OPA1) Protein in Lung Adenocarcinoma | unknown | — | 100 | China Medical University HospitalOTHER | 1 | Nov 29, 2010 | clinicaltrials |
| NCT01249066 | Expression of AMP-activated Protein Kinase (AMPK) Protein in Lung Adenocarcinoma | unknown | — | 100 | China Medical University HospitalOTHER | 1 | Nov 29, 2010 | clinicaltrials |
| NCT00933816 | Study of Sorafenib In Combination With Low-dose 5-fluorouracil/Cisplatin (FP) Intraarterial Infusion Chemotherapy(SILIUS) | completed | Phase 1 / Phase 2 | 37 | Kindai UniversityOTHER | 1 | Nov 25, 2010 | clinicaltrials |
| NCT01247506 | Different Genetic Features Associated With Hepatic Carcinogenesis | unknown | — | 160 | National Taiwan University HospitalOTHER | 1 | Nov 24, 2010 | clinicaltrials |
| NCT00156286 | Gleevec Maintenance Therapy After Induction Irinotecan and Cisplatin in Patients With C-Kit Positive Extensive SCLC | completed | Phase 2 | 20 | University of Michigan Rogel Cancer CenterOTHER | 1 | Nov 16, 2010 | clinicaltrials |
| NCT00460798 | SUTENT® In The First Line Treatment Of Renal Cell Carcinoma(SUNIKA) | completed | — | 356 | PfizerINDUSTRY | 0 | Nov 16, 2010 | clinicaltrials |
| NCT01240005 | Cytokine Induced Killer Cells Stimulated by DC Immunotherapy for Renal Cell Carcinoma | unknown | Phase 1 / Phase 2 | 30 | Qingdao UniversityOTHER | 1 | Nov 15, 2010 | clinicaltrials |
| NCT00509704 | Influence of Sutent on Tumor Vascularization and Necrosis in Patients With Renal Cell Carcinoma | completed | — | 10 | Radboud University Medical CenterOTHER | 1 | Nov 9, 2010 | clinicaltrials |
| NCT00768937 | Sorafenib and Transarterial Chemoembolization for Hepatocellular Carcinoma | completed | Phase 1 / Phase 2 | 22 | Medical University of ViennaOTHER | 1 | Nov 9, 2010 | clinicaltrials |
| NCT01237132 | East-West Hepatocellular Carcinoma Study Group | completed | — | — | University of MilanOTHER | 0 | Nov 9, 2010 | clinicaltrials |
| NCT00478374 | Sorafenib With TACE to Treat Hepatocellular Carcinoma(S-TACE) | completed | Phase 1 | 21 | University of BernOTHER | 1 | Nov 2, 2010 | clinicaltrials |
| NCT00789841 | Gastrointestinal Motility in Patients With Neuroendocrine Tumors | completed | — | 13 | University of AarhusOTHER | 1 | Oct 26, 2010 | clinicaltrials |
| NCT01222936 | LBH Phase II in Small Cell Lung Cancer (SCLC) | completed | Phase 2 | 21 | Southern Europe New Drug OrganizationOTHER | 2 | Oct 18, 2010 | clinicaltrials |
| NCT00077974 | A Pivotal Study Of SU011248 In The Treatment Of Patients With Cytokine-Refractory Metastatic Renal Cell Carcinoma. | completed | Phase 2 | 106 | PfizerINDUSTRY | 1 | Oct 13, 2010 | clinicaltrials |
| NCT00715637 | Phase III Randomized Study of Amonafide (AS1413) and Cytarabine Versus Daunorubicin and Cytarabine in Patients With Secondary Acute Myeloid Leukemia (AML)- the ACCEDE Study | unknown | Phase 3 | 420 | Antisoma ResearchINDUSTRY | 23 | Oct 13, 2010 | clinicaltrials |
| NCT00428597 | A Study Of Sunitinib Compared To Placebo For Patients With Advanced Pancreatic Islet Cell Tumors | terminated | Phase 3 | 171 | PfizerINDUSTRY | 11 | Oct 11, 2010 | clinicaltrials |
| NCT00430261 | Phase II Trial of Sunitinib in BAC or Never-Smokers With Any Lung Adenocarcinoma | completed | Phase 2 | 20 | Swedish Medical CenterOTHER | 1 | Oct 6, 2010 | clinicaltrials |
| NCT00895674 | Patient Characteristics in Advanced Renal Cell Carcinoma and Daily Practice Treatment With Nexavar | completed | — | 2,840 | BayerINDUSTRY | 18 | Sep 30, 2010 | clinicaltrials |
| NCT01201096 | Neo-adjuvant Peptide Receptor Mediated Radiotherapy With 177Lutetium in Front of Curative Intended Liver Transplantation in Patients With Hepatic Metastasis of Neuroendocrine Tumors (NEO-LEBE)(NEO-LEBE) | unknown | — | 50 | University of JenaOTHER | 1 | Sep 23, 2010 | clinicaltrials |
Data updated 23 days agoSource updated May 2, 2011source: clinicaltrials